Solicitation of Nominations for Appointment to the Advisory Committee on Breast Cancer in Young Women, 90699-90700 [2024-26784]
Download as PDF
90699
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices
programs, healthcare systems, and
professional and advocacy organizations
to guide program investments, provide
up-to-date information on symptom
presentation, healthcare utilization
patterns, and patient recovery among
others, and to provide information on
prevention of TBI.
Data obtained from this data
collection are not available from
currently existing databases, and the
data needed for analysis cannot be
added to existing data collection
processes. This data collection will
occur over three years. After each data
collection year, findings will be
reviewed to identify potential
modifications to the methodology and
survey for following year collection.
Depending on the nature and scope of
the improvements, a change request or
a Revision package will be submitted to
OMB for review and approval. CDC
requests OMB approval for an estimated
5,656 annual burden hours. There is no
cost to respondents other than their time
to participate.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total burden
(in hours)
Form name
Individuals and Households .......
Initial Invitation Letter ..............................
Reminder Postcard .................................
Final Reminder Letter .............................
Text Message Reminder .........................
Screener ..................................................
Survey, web ............................................
Survey, phone .........................................
57,405
53,312
50,583
27,696
10,058
8,682
1,318
1
1
1
1
1
1
1
1/60
1/60
1/60
1/60
4/60
11/60
11/60
957
889
843
462
671
1592
242
Total ....................................
.................................................................
........................
........................
........................
5,656
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–26777 Filed 11–15–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory
Committee on Breast Cancer in Young
Women
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
AGENCY:
ACTION:
Notice.
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), within the
Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Advisory
Committee on Breast Cancer in Young
Women (ACBCYW). The ACBCYW
consists of up to 15 experts in fields
associated with breast cancer, disease
prevention, early detection, diagnosis,
public health, social marketing, genetic
screening and counseling, treatment,
rehabilitation, palliative care, and
survivorship in young women, or in
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondent
VerDate Sep<11>2014
17:17 Nov 15, 2024
Jkt 265001
related disciplines with a specific focus
on young women.
DATES: Nominations for membership on
the ACBCYW must be received no later
than December 16, 2024. Packages
received after this time will not be
considered for the current membership
cycle.
ADDRESSES: All nominations should be
mailed to Kimberly E. Smith, M.B.A.,
M.H.A., c/o ACBCYW Secretariat,
Centers for Disease Control and
Prevention, 3719 North Peachtree Road,
Building 100, Chamblee, Georgia 30341
or emailed to acbcyw@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Kimberly E. Smith, M.B.A., M.H.A.,
Designated Federal Officer, National
Center for Chronic Disease Prevention
and Health Promotion, Centers for
Disease Control and Prevention, 4770
Buford Highway NE, Mailstop S107–4,
Atlanta, Georgia 30341. Telephone:
(404) 498–0073; Email: acbcyw@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are sought for individuals
who have the expertise and
qualifications necessary to contribute to
the accomplishment of the objectives of
the Advisory Committee on Breast
Cancer in Young Women (ACBCYW).
Nominees will be selected based on
expertise in the fields of breast health,
breast cancer, disease prevention and
risk reduction, survivorship (including
metastatic breast cancer), hereditary
breast and ovarian cancer, or in related
disciplines with a specific focus on
young women. Persons with personal
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
experience with early onset breast
cancer are also eligible to apply. This
includes but may not be limited to
breast cancer survivors 45 years of age
or younger, and caregivers of said
persons. Federal employees will not be
considered for membership. Members
may be invited to serve up to four-year
terms. Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACBCYW
objectives (https://www.cdc.gov/breastcancer/php/advisory-committee/).
Department of Health and Human
Services (HHS) policy stipulates that
committee membership be balanced in
terms of points of view represented and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on Federal workgroups or
prior experience serving on a Federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning of and annually during their
terms. The Centers for Disease Control
and Prevention (CDC) reviews potential
candidates for ACBCYW membership
each year and provides a slate of
E:\FR\FM\18NON1.SGM
18NON1
90700
Federal Register / Vol. 89, No. 222 / Monday, November 18, 2024 / Notices
nominees for consideration to the
Secretary of HHS for final selection.
HHS notifies selected candidates of
their appointment near the start of the
term in December 2025, or as soon as
the HHS selection process is completed.
Note that the need for different expertise
varies from year to year and a candidate
who is not selected in one year may be
reconsidered in a subsequent year.
Candidates should submit the
following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by HHS. Candidates may
submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (e.g., CDC,
National Institutes of Health, Food and
Drug Administration).
D A short biography (150 words or
less).
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–26784 Filed 11–15–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–25–24FZ]
lotter on DSK11XQN23PROD with NOTICES1
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Annual
Progress Reports for Injury Control
Research Centers (ICRC)’’ to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
VerDate Sep<11>2014
17:17 Nov 15, 2024
Jkt 265001
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on June 4,
2024 to obtain comments from the
public and affected agencies. CDC
received one non-substantive comment
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Annual Progress Reports for Injury
Control Research Centers (ICRC)—
New—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Background and Brief Description
In 1987, the Centers for Disease
Control and Prevention (CDC) and the
National Center for Injury Prevention
and Control (NCIPC) began funding
Injury Control Research Centers (ICRCs)
at academic research institutions
throughout the United States. ICRCs
focus on three core functions—research,
training, and outreach—for issues of
local and national importance,
including the prevention of adverse
childhood experiences; child abuse and
neglect; drowning; drug overdose;
intimate partner violence; older adult
falls; sexual violence; suicide; traumatic
brain injuries, and the promotion of
transportation safety. ICRCs foster
multidisciplinary strategies for
addressing these complex problems and
disseminating research findings. In
addition to conducting cutting-edge,
multidisciplinary research, ICRCs train
and develop the current and next
generation of researchers and public
health professionals to help ensure that
there is an adequate supply of qualified
practitioners and researchers for
advancing prevention research,
addressing new problems, and reaching
new populations across the nation.
Finally, ICRCs work with states and
communities to translate research
findings into action. ICRCs provide
partner organizations with technical
assistance on programs, public health
infrastructure, and the integration of
resources at the local, state, and national
levels. Areas of emphasis within each
ICRC are determined by the expertise of
the faculty and the public health needs
and opportunities identified through the
ICRC’s outreach activities. This
collaborative approach is a vital
component in the success of efforts to
make an impact on population-level
reduction in injury-related harm.
ICRCs form a national network of
expertise and innovation in injury
prevention and control. ICRC grants are
typically funded in five-year funding
cycles. The Centers for Disease Control
and Prevention (CDC) requests OMB
approval to electronically collect annual
progress report (APR) information and
Success Stories from the 11 currently
funded ICRCs. Grantees will report
progress and activity information to
CDC on an annual schedule.
The information that will be collected
will provide crucial data for program
performance monitoring and will
improve CDC’s ability to respond in a
timely manner to requests for
information about the program from the
Department of Health and Human
Services (HHS), the White House,
Congress, and other sources. The
E:\FR\FM\18NON1.SGM
18NON1
Agencies
[Federal Register Volume 89, Number 222 (Monday, November 18, 2024)]
[Notices]
[Pages 90699-90700]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26784]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Advisory
Committee on Breast Cancer in Young Women
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), within the Department
of Health and Human Services (HHS), is seeking nominations for
membership on the Advisory Committee on Breast Cancer in Young Women
(ACBCYW). The ACBCYW consists of up to 15 experts in fields associated
with breast cancer, disease prevention, early detection, diagnosis,
public health, social marketing, genetic screening and counseling,
treatment, rehabilitation, palliative care, and survivorship in young
women, or in related disciplines with a specific focus on young women.
DATES: Nominations for membership on the ACBCYW must be received no
later than December 16, 2024. Packages received after this time will
not be considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to Kimberly E. Smith,
M.B.A., M.H.A., c/o ACBCYW Secretariat, Centers for Disease Control and
Prevention, 3719 North Peachtree Road, Building 100, Chamblee, Georgia
30341 or emailed to [email protected].
FOR FURTHER INFORMATION CONTACT: Kimberly E. Smith, M.B.A., M.H.A.,
Designated Federal Officer, National Center for Chronic Disease
Prevention and Health Promotion, Centers for Disease Control and
Prevention, 4770 Buford Highway NE, Mailstop S107-4, Atlanta, Georgia
30341. Telephone: (404) 498-0073; Email: [email protected].
SUPPLEMENTARY INFORMATION: Nominations are sought for individuals who
have the expertise and qualifications necessary to contribute to the
accomplishment of the objectives of the Advisory Committee on Breast
Cancer in Young Women (ACBCYW). Nominees will be selected based on
expertise in the fields of breast health, breast cancer, disease
prevention and risk reduction, survivorship (including metastatic
breast cancer), hereditary breast and ovarian cancer, or in related
disciplines with a specific focus on young women. Persons with personal
experience with early onset breast cancer are also eligible to apply.
This includes but may not be limited to breast cancer survivors 45
years of age or younger, and caregivers of said persons. Federal
employees will not be considered for membership. Members may be invited
to serve up to four-year terms. Selection of members is based on
candidates' qualifications to contribute to the accomplishment of
ACBCYW objectives (https://www.cdc.gov/breast-cancer/php/advisory-committee/).
Department of Health and Human Services (HHS) policy stipulates
that committee membership be balanced in terms of points of view
represented and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on Federal workgroups or prior experience serving
on a Federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees, requiring the filing of
financial disclosure reports at the beginning of and annually during
their terms. The Centers for Disease Control and Prevention (CDC)
reviews potential candidates for ACBCYW membership each year and
provides a slate of
[[Page 90700]]
nominees for consideration to the Secretary of HHS for final selection.
HHS notifies selected candidates of their appointment near the start of
the term in December 2025, or as soon as the HHS selection process is
completed. Note that the need for different expertise varies from year
to year and a candidate who is not selected in one year may be
reconsidered in a subsequent year.
Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
[ssquf] At least one letter of recommendation from person(s) not
employed by HHS. Candidates may submit letter(s) from current HHS
employees if they wish, but at least one letter must be submitted by a
person not employed by an HHS agency (e.g., CDC, National Institutes of
Health, Food and Drug Administration).
[ssquf] A short biography (150 words or less).
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-26784 Filed 11-15-24; 8:45 am]
BILLING CODE 4163-18-P